SCHEDULE 13G/A: Nuveen Asset Management and Affiliates Disclose 2.41% Passive Stake in Guardian Pharmacy Services

Sentiment:

Beneficial Ownership Disclosure


Nuveen Asset Management, LLC and its affiliated entities have filed an amended Schedule 13G, revealing a collective passive beneficial ownership of 2.41% in Guardian Pharmacy Services, Inc.

Summary

  • Nuveen Asset Management, LLC (NAM) filed an Amendment No. 1 to Schedule 13G, disclosing its beneficial ownership in Guardian Pharmacy Services, Inc.
  • Collectively, Nuveen Asset Management, LLC and its affiliates, TIAA-CREF Investment Management, LLC (TCIM) and Teachers Advisors, LLC (TAL), beneficially own an aggregate of 547,739 shares of Guardian Pharmacy Services, Inc. common stock.
  • This aggregate holding represents 2.41% of the total class of securities.
  • Specifically, Nuveen Asset Management, LLC directly holds 69,312 shares, which accounts for 0.31% of the class, over which it exercises sole voting and dispositive power.
  • TIAA-CREF Investment Management, LLC is deemed a beneficial owner of 467,986 shares held by the College Retirement Equities Fund (CREF).
  • Teachers Advisors, LLC is deemed a beneficial owner of 10,441 shares held by various TIAA-CREF funds and separate accounts.
  • The filing certifies that these securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Guardian Pharmacy Services, Inc.

Sentiment

Score: 5

Explanation: Neutral. This is a routine disclosure filing (Schedule 13G) indicating passive ownership by an institutional investor. It does not contain information that would typically drive positive or negative sentiment about the issuer's performance or prospects.

Positives

  • Nuveen Asset Management, a significant institutional investor, maintains a passive investment in Guardian Pharmacy Services, Inc., indicating continued confidence.
  • The investment is explicitly stated to be for ordinary course of business, not for influencing control, suggesting stability in the shareholder base.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future outlook.

Management Comments

  • The securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.

Industry Context

This Schedule 13G filing reflects a routine disclosure by an institutional investment manager regarding its passive stake in a company within the pharmacy services sector. Such filings are common and indicate ongoing investment activity by large asset managers in publicly traded companies.

Comparison to Industry Standards

  • As a routine Schedule 13G filing, this document does not provide performance metrics for comparison to industry standards. It solely reports beneficial ownership by an institutional investor.

Stakeholder Impact

  • This filing primarily impacts shareholders by providing transparency on significant institutional ownership. It indicates a stable, passive investment by a major asset manager, which can be viewed positively by other investors.

Key Dates

DateDescription
05/30/2025Date of event requiring the filing of this statement
06/06/2025Signature date of the filing

Keywords

Guardian Pharmacy Services, Nuveen Asset Management, SEC Filing, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Pharmacy Services

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.